A. Collier Smyth
Plus aucun poste en cours
Profil
A.
Collier Smyth is the founder of New Hampshire Oncology-Hematology PA, which was founded in 1976.
Smyth held the title of President at the company.
Smyth's former jobs include Director at ARIAD Pharmaceuticals, Inc. from 2009 to 2011, Independent Director at EpiCept Corp.
from 2011 to 2012, Senior Vice President-Medical Strategy at Bristol Myers Squibb Co. in 2009, and Vice President-Medical Affairs at US Oncology, Inc. Smyth received a doctorate degree from The Johns Hopkins University and an undergraduate degree from Lehigh University.
Anciens postes connus de A. Collier Smyth
| Sociétés | Poste | Fin |
|---|---|---|
EpiCept Corp.
 EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Directeur/Membre du Conseil | 28/08/2012 |
| ARIAD PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 28/04/2011 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/03/2009 |
New Hampshire Oncology-Hematology PA
 New Hampshire Oncology-Hematology PA Hospital/Nursing ManagementHealth Services New Hampshire Oncology-Hematology PA provides healthcare survives. The company was founded by Collier A. Smyth in 1976 and is headquartered in Hooksett, NH. | Fondateur | - |
US Oncology, Inc.
 US Oncology, Inc. Medical/Nursing ServicesHealth Services US Oncology, Inc. engages in the provision of cancer care servicers. It offers therapies, depending on such things as type of cancer, stage at diagnosis and the patient’s overall health such as chemotherapy, radiotherapy, surgery, hormone therapy, and immunotherapy. The company was founded in 1999 and is headquartered in The Woodlands, TX. | Directeur Technique/Scientifique/R&D | - |
Formation de A. Collier Smyth
| Lehigh University | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 4 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
EpiCept Corp.
EpiCept Corp. Pharmaceuticals: MajorHealth Technology EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY. | Health Technology |
US Oncology, Inc.
US Oncology, Inc. Medical/Nursing ServicesHealth Services US Oncology, Inc. engages in the provision of cancer care servicers. It offers therapies, depending on such things as type of cancer, stage at diagnosis and the patient’s overall health such as chemotherapy, radiotherapy, surgery, hormone therapy, and immunotherapy. The company was founded in 1999 and is headquartered in The Woodlands, TX. | Health Services |
New Hampshire Oncology-Hematology PA
New Hampshire Oncology-Hematology PA Hospital/Nursing ManagementHealth Services New Hampshire Oncology-Hematology PA provides healthcare survives. The company was founded by Collier A. Smyth in 1976 and is headquartered in Hooksett, NH. | Health Services |